Back to
Michala Kowalski

Michala Kowalski

PhD Candidate
Arts, Design & Architecture
Social Policy Research Centre

Email: m.kowalski@unsw.edu.au

Supervisors: Alison Ritter, Claire Wilkinson, Michael Livingston

Michala Kowalski is a Scientia PhD candidate at the Social Policy Research Centre, studying the nighttime alcohol policy ecosystem in New South Wales using a mixed methods approach. Michala joined the Drug Policy Modelling Program as a research officer in 2017 and is a member of the Global Cannabis Cultivation Research Consortium. Her research interests include night-time economies, cannabis, cryptomarkets, drug and alcohol treatment, opioid use, harm reduction and technology.
Alcohol policy
  • Kowalski M., Livingston M., Wilkinson C., Ritter A. (2023) An overlooked effect: domestic violence and alcohol policies in the night-time economy. Addiction.
  • Kowalski M., Livingston M., Wilkinson C., Ritter A. (2023) The impact of tableside ordering technologies on alcohol sales to the intoxicated. Drug and Alcohol Review.
  • Kowalski M., Wilkinson C., Livingston M., Ritter A. (2023) Piloting a classification framework for the types of evidence used in alcohol policymaking. Drug and Alcohol Review; 1-12.
  • McLauchlan L., Kelaita P., Kowalski M. & Ritter A. (2023) Post-Retirement Enlightenment Syndrome International Journal of Drug Dependence.
  • Nielsen S., Barratt M., Hiley S., Bartlett M., Latimer J., Jauncey M., Roux C., Morelato M., Clark N., Kowalski M., Gilbert M., Francia L., Shipton A., Gerostamoulos D., Glowacki L., Lam T. (2023) Monitoring for fentanyl within Australian supervised injecting facilities: Findings from feasibility testing of novel methods and collaborative workshops International Journal of Drug Policy.
  • O’Reilly K., Kowalski M., Barratt M.J., Ritter A. (2022) Distinguishing personal use of drugs from drug supply: approaches and challenges. International Journal of Drug Policy 103.
  • Wilkinson C., Dwyer R., Kowalski M. (2022) News media both represents and acts: Commentary on Howse et. al. news media content analysis of Sydney's ‘last drinks' laws. Drug and Alcohol Review 41(3): 575.
  • Nielsen S., Sanfilippo P., Picco L., Bruno R., Kowalski M., Wood P., Larney S. (2021) What predicts pharmacists' engagement with opioid-outcome screening? Secondary analysis from an implementation study in community pharmacy. International Journal of Clinical Pharmacy 43(2): 420-429.
  • Picco L., Middleton M., Bruno R, Kowalski M., Nielsen S. (2020) Validity and reliability of the online Routine Opioid Outcome Monitoring (ROOM) tool. Pain Medicine 21(12): 3645-3654.
  • Barratt M.J., Kowalski M., Volpe I., Maier L.J. (2020) On-site drug checking can provide quantitative analysis: Response to Scott & Scott. Internal Medicine Journal 50(8): 1022-1023.
  • Nielsen S., Picco L., Kowalski M., Sanfilippo P., Wood P., Larney S., Bruno R., Ritter A. (2020) Routine Opioid Outcome Monitoring in Community Pharmacy: Outcomes from an open-label single-arm implementation-effectiveness pilot study. Research in Social and Administrative Pharmacy 16(12): 1694-1701.
  • Picco L., Middleton M., Bruno R., Kowalski M., Nielsen S. (2020) Validation of the OWLS, a screening tool for measuring prescription opioid use disorder in primary care. Pain Medicine 21(11): 2757-2764.
  • Kowalski M., Hooker C., Barratt M.J. (2019) Should we smoke it for you as well? An ethnographic analysis of a drug cryptomarket environment. International Journal of Drug Policy 73: 25-254 doi.org/10.1016/j.drugpo.2019.03.011.
  • Nielsen S., Kowalski M., Wood P., Larney S., Bruno R., Shanahan M., Lenton S., Dietze P., Green T., Murnion B., Ritter A. (2018) Routine Opioid Outcome Monitoring in Community Pharmacy: Pilot implementation study protocol. Research in Social and Administrative Pharmacy. doi: 10.1016/j.sapharm.2018.10.024.